Immune Netw.  2016 Feb;16(1):52-60. 10.4110/in.2016.16.1.52.

Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications

Affiliations
  • 1System Immunology Laboratory, Department of Biochemistry, College of Life Science & Biotechnology, Yonsei University, Seoul 03722, Korea. sjha@yonsei.ac.kr

Abstract

Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that bridge innate and adaptive immune responses, thereby leading to immune activation. DCs have been known to recognize pathogen-associated molecular patterns such as lipopolysaccharides (LPS) and nucleic acids via their pattern recognition receptors, which trigger signaling of their maturation and effector functions. Furthermore, DCs take up and process antigens as a form of peptide loaded on the major histocompatibility complex (MHC) and present them to T cells, which are responsible for the adaptive immune response. Conversely, DCs can also play a role in inducing immune suppression under specific circumstances. From this perspective, the role of DCs is related to tolerance rather than immunity. Immunologists refer to these special DCs as tolerogenic DCs (tolDCs). However, the definition of tolDCs is controversial, and there is limited information on their development and characteristics. In this review, we discuss the current concept of tolDCs, cutting-edge methods for generating tolDCs in vitro, and future applications of tolDCs, including clinical use.

Keyword

Tolerogenic dendritic cell; In vitro generation; Clinical use

MeSH Terms

Adaptive Immunity
Antigen-Presenting Cells
Dendritic Cells*
Lipopolysaccharides
Major Histocompatibility Complex
Nucleic Acids
Receptors, Pattern Recognition
T-Lymphocytes
Lipopolysaccharides
Nucleic Acids
Receptors, Pattern Recognition
Full Text Links
  • IN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr